Loading…
Held by equity mutual funds in 64 disclosed months, Jun 2021 to Sep 2026.
Orchid Pharma Limited (Pharmaceuticals & Biotechnology) was held by 18 active equity mutual funds in September 2026, ₹904 Cr in all (up 0 funds from Aug 2026). The largest position was Kotak Special Opportunities Fund at 2.5% of its portfolio. During the month 0 funds entered and 0 exited. Funds have disclosed holding it since Jun 2021.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
None.
None.
How many equity funds held the company each month, and the value they held.
None.